Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 298

Similar articles for PubMed (Select 21280185)

1.

Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.

Liver Transpl. 2011 Feb;17(2):129-36. doi: 10.1002/lt.22218.

2.

A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.

Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM.

Gastroenterology. 2011 Jun;140(7):1952-60. doi: 10.1053/j.gastro.2011.02.017. Epub 2011 Feb 18.

PMID:
21334338
3.

Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.

Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.

Transplant Proc. 2012 Mar;44(2):389-92. doi: 10.1016/j.transproceed.2012.01.037.

PMID:
22410024
4.

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.

Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.

Hepatology. 2012 Jan;55(1):192-8. doi: 10.1002/hep.24632. Epub 2011 Nov 15. Erratum in: Hepatology. 2012 Apr;55(4):1311.

5.

MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.

Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC; Liver Transplantation Group.

Clin Transplant. 2012 Jul-Aug;26(4):E395-401. doi: 10.1111/j.1399-0012.2012.01688.x.

PMID:
22882694
6.

Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.

Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.

PMID:
23026574
7.

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.

Liver Transpl. 2012 Dec;18(12):1456-63. doi: 10.1002/lt.23548.

8.

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA.

Hepatology. 2004 Oct;40(4):802-10.

PMID:
15382176
9.

Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.

Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P.

BMC Gastroenterol. 2009 Sep 25;9:72. doi: 10.1186/1471-230X-9-72.

10.

The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.

Renfrew PD, Quan H, Doig CJ, Dixon E, Molinari M.

Can J Gastroenterol. 2011 Jul;25(7):359-64.

11.

Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.

J Gastroenterol. 2014 Feb;49(2):324-31. doi: 10.1007/s00535-013-0782-5. Epub 2013 Mar 12.

PMID:
23478939
12.

Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list.

Porrett PM, Baranov E, ter Horst M.

Transplantation. 2015 Jan;99(1):158-63. doi: 10.1097/TP.0000000000000299.

PMID:
25050469
13.

Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.

Rahimi-Dehkordi N, Nourijelyani K, Nasiri-Tousi M, Ghodssi-Ghassemabadi R, Azmoudeh-Ardalan F, Nedjat S.

Arch Iran Med. 2014 Feb;17(2):118-21. doi: 014172/AIM.007.

14.

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW.

PLoS One. 2013;8(1):e51926. doi: 10.1371/journal.pone.0051926. Epub 2013 Jan 18.

15.

Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure.

Pugliese R, Fonseca EA, Porta G, Danesi V, Guimaraes T, Porta A, Miura IK, Borges C, Candido H, Benavides M, Feier FH, Godoy A, Cardoso RA, Kondo M, Chapchap P, Neto JS.

Hepatology. 2014 May;59(5):1964-71. doi: 10.1002/hep.26776. Epub 2014 Apr 1.

PMID:
24122953
16.

How much is too much?

McCashland TM.

Liver Transpl. 2011 Feb;17(2):102-3. doi: 10.1002/lt.22241. No abstract available.

17.

Impact of MELD score implementation on liver allocation: experience at a Brazilian center.

da Silva Machado AG, de Medeiros Fleck A Jr, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.

Ann Hepatol. 2013 May-Jun;12(3):440-7.

PMID:
23619261
18.

Hyponatremia and mortality among patients on the liver-transplant waiting list.

Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM.

N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.

19.

Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.

Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.

Hepatology. 2011 Oct;54(4):1313-21. doi: 10.1002/hep.24494.

20.

Variation in access to the liver transplant waiting list in the United States.

Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, Kalbfleisch J.

Transplantation. 2014 Jul 15;98(1):94-9. doi: 10.1097/01.TP.0000443223.89831.85.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk